Method for generating aptamers with improved off-rates
The present disclosure describes improved SELEX methods for producing aptamers that are capable of binding to target molecules and improved photoSELEX methods for producing photoreactive aptamers that are capable of both binding and covalently crosslinking to target molecules. Specifically, the present disclosure describes methods for producing aptamers and photoaptamers having slower dissociation rate constants than are obtained using prior SELEX and photoSELEX methods. The disclosure further describes aptamers and photoaptamers having slower dissociation rate constants than those obtained using prior methods. In addition, the disclosure describes aptamer constructs that include a variety of functionalities, including a cleavable element, a detection element, and a capture or immobilization element.
1. A method of identifying or producing an aptamer having a slow rate of dissociation (t 1/2 ) from its target molecule, the method comprising:
(a) preparing a candidate mixture of nucleic acids, wherein the candidate mixture comprises modified nucleic acids in which one, several or all pyrimidines in at least one, or each, nucleic acid of the candidate mixture comprises a chemical modification at a C-5 position;
(b) contacting the candidate mixture with a target molecule and exposing the candidate mixture to a slow off-rate enrichment process, wherein nucleic acids having a slow rate of dissociation from the target molecule relative to other nucleic acids in the candidate mixture bind the target molecule, forming nucleic acid-target molecule complexes;
(c) partitioning slow off-rate nucleic acids from the candidate mixture; and
(d) amplifying the slow off-rate nucleic acids to yield a mixture of nucleic acids enriched in nucleic acid sequences that are capable of binding to the target molecule with a slow off-rate,
whereby a slow off-rate aptamer to the target molecule may be identified.
2. A method of producing an aptamer having a slow rate of dissociation (t 1/2 ) from its target molecule, said method comprising the step of preparing or synthesizing an aptamer based on a nucleic acid sequence identified by a process comprising the steps of:
(a) preparing a candidate mixture of nucleic acids, wherein the candidate mixture comprises modified nucleic acids in which one, several or all pyrimidines in at least one, or each, nucleic acid of the candidate mixture comprises a chemical modification at a C-5 position;
(b) contacting the candidate mixture with a target molecule and exposing the candidate mixture to a slow off-rate enrichment process, wherein nucleic acids having a slow rate of dissociation from the target molecule relative to other nucleic acids in the candidate mixture bind the target molecule, forming nucleic acid-target molecule complexes;
(c) partitioning slow off-rate nucleic acids from the candidate mixture; and
(d) amplifying the slow off-rate nucleic acids to yield a mixture of nucleic acids enriched in nucleic acid sequences that are capable of binding to the target molecule with a slow off-rate,
whereby a slow off-rate aptamer to the target molecule is identified.
3. A method according to claim 1 wherein said chemical modification at a C-5 position is independently chosen from at least one of the modifications shown in FIG. 14 .
4. The method of claim 3 , wherein said aptamer further comprises at least one additional chemical modification.
5. The method of claim 4 , wherein said at least one additional chemical modification is a chemical substitution at one or more positions independently selected from the group consisting of a ribose position, a deoxyribose position, a phosphate position, and a base position.
6. The method of claim 5 , wherein said at least one additional chemical modification is independently selected from the group consisting of a 2′-position sugar modification, a 2′-amino (2′-NH 2 ), a 2′-fluoro (2′-F), a 2′-O-methyl (2′-OMe) a modification at a cytosine exocyclic amine, a substitution of 5-bromouracil, a substitution of 5-bromodeoxyuridine, a substitution of 5-bromodeoxycytidine, a backbone modification, methylation, a 3′ cap, and a 5′ cap.
7. The method of claim 3 , wherein said modification at a C-5 position is independently selected from the group consisting of 5-(N-benzylcarboxyamide)-2′-deoxyuridine, 5-(N-isobutylcarboxyamide)-2′-deoxyuridine, 5-(N-naphthylmethylcarboxyamide)-2′-deoxyuridine, and 5-(N-tryptaminocarboxyamide)-2′-deoxyuridine.
8. The method of claim 1 wherein said target molecule is selected from the group consisting of a protein, a carbohydrate, a polysaccharide, a glycoprotein, a hormone, a receptor, a peptide, an antigen, an antibody, a virus, a substrate, a metabolite, a transition state analog, a cofactor, an inhibitor, a drug, a dye, a nutrient, a growth factor, a tissue, and a controlled substance.
9. The method of claim 1 wherein said rate of dissociation (t 1/2 ) is greater than or equal to about 30 minutes.
10. The method of claim 9 wherein said rate of dissociation (t 1/2 ) is between about 30 minutes and about 240 minutes.
11. The method of claim 10 wherein said rate of dissociation (t 1/2 ) is selected from the group consisting of a time≧ about 30 minutes, ≧ about 60 minutes, ≧ about 90 minutes, ≧ about 120 minutes, ≧ about 150 minutes, ≧ about 180 minutes, ≧ about 210 minutes and ≧ about 240 minutes.
12. The method of claim 1 , wherein said slow off-rate aptamer comprises a detectable moiety.
13. The method of claim 12 , wherein said detectable moiety is selected from the group consisting of a dye, a quantum dot, a radiolabel, a electrochemical functional group, an enzyme, an enzyme substrate, a ligand and a receptor.
14. The method of claim 1 , wherein said slow off-rate aptamer is a single-stranded nucleic acid or a double-stranded nucleic acid.
15. The method of claim 1 , wherein said slow off-rate aptamer comprises DNA, RNA, or both DNA and RNA.
16. The method of claim 1 , wherein said slow off-rate aptamer is capable of forming a covalent bond with the target.
17. The method of claim 16 , wherein said slow off-rate aptamer is a photoaptamer.
18. The method according to claim 2 wherein said chemical modification at a C-5 position is independently chosen from at least one of the modifications shown in FIG. 14 .
19. The method of claim 18 , wherein said chemical modification at a C-5 position is independently selected from the group consisting of 5-(N-benzylcarboxyamide)-2′-deoxyuridine, 5-(N-isobutylcarboxyamide)-2′-deoxyuridine, 5-(N-naphthylmethylcarboxyamide)-2′-deoxyuridine, and 5-(N-tryptaminocarboxyamide)-2′-deoxyuridine.
20. The method of claim 18 , wherein said aptamer further comprises at least one additional chemical modification.
21. The method of claim 20 , wherein said at least one additional chemical modification is a chemical substitution at one or more positions independently selected from the group consisting of a ribose position, a deoxyribose position, a phosphate position, and a base position.
22. The method of claim 21 , wherein said at least one additional chemical modification is independently selected from the group consisting of a 2′-position sugar modification, a 2′-amino (2′-NH 2 ), a 2′-fluoro (2′-F), a 2′-O-methyl (2′-OMe) a modification at a cytosine exocyclic amine, a substitution of 5-bromouracil, a substitution of 5-bromodeoxyuridine, a substitution of 5-bromodeoxycytidine, a backbone modification, methylation, a 3′ cap, and a 5′ cap.
23. The method of claim 2 wherein said target molecule is selected from the group consisting of a protein, a carbohydrate, a polysaccharide, a glycoprotein, a hormone, a receptor, a peptide, an antigen, an antibody, a virus, a substrate, a metabolite, a transition state analog, a cofactor, an inhibitor, a drug, a dye, a nutrient, a growth factor, a tissue, and a controlled substance.
24. The method of claim 2 wherein said rate of dissociation (t 1/2 ) is greater than or equal to about 30 minutes.
25. The method of claim 24 wherein said rate of dissociation (t 1/2 ) is between about 30 minutes and about 240 minutes.
26. The method of claim 25 wherein said rate of dissociation (t 1/2 ) is selected from the group consisting of a time≧ about 30 minutes, ≧ about 60 minutes, ≧ about 90 minutes, ≧ about 120 minutes, ≧ about 150 minutes, ≧ about 180 minutes, ≧ about 210 minutes and ≧ about 240 minutes.
27. The method of claim 2 , wherein said slow off-rate aptamer comprises a detectable moiety.
28. The method of claim 27 , wherein said detectable moiety is selected from the group consisting of a dye, a quantum dot, a radiolabel, a electrochemical functional group, an enzyme, an enzyme substrate, a ligand and a receptor.
29. The method of claim 2 , wherein said slow off-rate aptamer is a single-stranded nucleic acid or a double-stranded nucleic acid.
30. The method of claim 2 , wherein said slow off-rate aptamer comprises DNA, RNA, or both DNA and RNA.
31. The method of claim 2 , wherein said slow off-rate aptamer is capable of forming a covalent bond with the target.
32. The method of claim 31 , wherein said slow off-rate aptamer is a photoaptamer.
33. The method of claim 1 , wherein said slow off-rate enrichment process is selected from incubation of a candidate mixture with a competitor molecule, dilution of a candidate mixture, or dilution of a candidate mixture in the presence of a competitor molecule.
34. The method of claim 2 , wherein said slow off-rate enrichment process is selected from incubation of a candidate mixture with a competitor molecule, dilution of a candidate mixture, or dilution of a candidate mixture in the presence of a competitor molecule.